GPR30 is overexpressed in post-puberal testicular germ cell tumors

Cancer Biology and Therapy

Volumn 11, Issue 6, 2011, Pages 609-613

  Franco, Renato ^a   Boscia, Francesca ^a   Gigantino, Vincenzo ^a   Marra, Laura ^a   Esposito, Francesco ^a   Ferrara, Diana ^a   Pariante, Paolo ^a   Botti, Gerardo ^a   Caraglia, Michele ^a   Minucci, Sergio ^a   Chieffi, Paolo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Estrogen receptor; GPR30; Seminomas; Spermatogenesis; Testicular cancer

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR 30; RECEPTOR ANTIBODY;

ADULTHOOD; ARTICLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GENE OVEREXPRESSION; GENE TARGETING; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; SEMINOMA; SPERMATOGENESIS; SPERMATOGONIUM; TERATOMA; TESTIS CANCER; TESTIS TUMOR; WESTERN BLOTTING;

ADULT; ANTINEOPLASTIC AGENTS; CARCINOMA, EMBRYONAL; CELL TRANSFORMATION, NEOPLASTIC; DRUG DESIGN; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SEMINOMA; TERATOMA; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 79952762504     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.6.14672     Document Type: Article

References (32)

1. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumors in a broader perspective. Nat Rev Cancer 2005; 5:210-22. (Pubitemid 40314952)
2. Chieffi P. Molecular targets for the treatment of testicular germ cell tumors. Mini-Rev Med Chem 2007; 7:755-9. (Pubitemid 47099175)
3. Chieffi P, Franco R, Portella G. Molecular and cell biology of testicular tumors. Int Rev Cell Mol Biol 2009; 278:277-308.
4. Pais V, Leav I, Lau KM, Jiang Z, Ho SM. Estrogen receptor-b expression in human testicular germ cell tumors. Clin Cancer Res 2003; 9:4475-82. (Pubitemid 37248406)
5. Hirvonen-Santti SJ, Rannikko A, Santti H, Savolainen S, Nyberg M, Jänne OA, et al. Downregulation of estrogen receptor beta and transcriptional coregulator SNURF/RNF4 in testicular germ cell cancer. Eur Urol 2003; 44:742-7. (Pubitemid 37542935)
6. Pettersson K, Gustafsson JÅ. Role of estrogen receptor beta in estrogen action. Ann Rev Physiol 2004; 63:165-92.
7. Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, et al. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 2006; 20:631-46. (Pubitemid 43291214)
8. Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, et al. 17beta-estradiol, genistein and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol Pharmacol 2006; 70:1414-23. (Pubitemid 44435994)
9. Langer G, Bader B, Meoli L, Isensee J, Delbeck M, Noppinger PR, et al. A critical review of fundamental controversies in the field of GPR30 research. Steroids 2010; 75:603-10.
10. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30 and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000; 14:1649-60.
11. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005; 307:1625-30. (Pubitemid 40354745)
12. Albanito L, Sisci D, Aquila S, Brunelli E, Vivacqua A, Madeo A, et al. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. Endocrinol 2008; 49:3799-808.
13. Filardo EJ, Thomas P. GPR30: A seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 2005; 16:362-7. (Pubitemid 41338741)
14. Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, et al. GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol 2006; 114:465-71.
15. Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, DeLellis RA, et al. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res 2006; 12:6359-66. (Pubitemid 44799705)
16. Smith HO, Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE, et al. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol 2007; 196:386.
17. Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, et al. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 2007; 67:1859-66. (Pubitemid 46383413)
18. Sirianni R, Chimento A, Ruggiero C, De Luca A, Lappano R, Andò S, et al. The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line. Endocrinol 2008; 149:5043-51.
19. Hofmann MC, Narisava S, Hess RA, Millan JL. Immortalization of germ cells and somatic testicular cells using the SV40 large T antigen. Exp Cell Res 1992; 201:417-35.
20. Mizuno Y, Gotoh A, Kamidono S, Kitazawa S. Establishment and characterization of a new human testicular germ cell tumor cell line (TCam-2). Nippon Hinyokika Gakkai Zasshi 1993; 84:1211-8. (Pubitemid 23275551)
21. De Jong J, Stoop H, Gillis AJ, Hersmus R, van Gurp RJ, van de Geijn GJ, et al. Further characterization of the first seminoma cell line TCam-2. Genes Chrom Cancer 2008; 47:185-96. (Pubitemid 351162849)
22. Senturia YD. The epidemiology of testicular cancer. Br J Urol 1987; 60:285-91. (Pubitemid 17147546)
23. Prossnitz ER, Sklar LA, Oprea TI, Arterburn JB. GPR30: a novel therapeutic target in estrogenrelated disease. Trends Pharmacol Sci 2008; 29:116-23.
24. Fischer OM, Hart S, Gschwind A, Ullrich A. EGFR signal transactivation in cancer cells. Biochem Soc Trans 2003; 31:1203-8.
25. Bologa CG, Revankar CM, Young SM, Edwards BS, Arterburn JB, Kiselyov AS, et al. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2006; 2:207-12.
26. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak T, et al. In vivo effects of a GPR30 antagonist. Nature Chem Biol 2009; 5:421-7.
27. Albanito L, Lappano R, Madeo A, Chimento A, Prossnitz ER, Cappello AR, et al. G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ Health Perspect 2008; 116:1648-55.
28. Chieffi P, Troncone G, Caleo A, Libertini S, Linardopoulos S, Tramontano D, et al. Aurora B expression in normal testis and seminomas. J Endocrinol 2004; 181:263-70. (Pubitemid 38744675)
29. Fedele M, Franco R, Salvatore G, Paronetto MP, Barbagallo F, Pero R, et al. PATZ1 gene has a critical role in the spermatogenesis and testicular tumours. J Pathol 2008; 215:39-47.
30. Franco R, Esposito F, Fedele M, Liguori G, Pierantoni G, Botti G, et al. Detection of high mobility group proteins A1 and A2 represents a valid diagnostic marker in post-puberal testicular germ cell tumours. J Pathol 2008; 214:58-64.
31. Esposito F, Libertini S, Franco R, Abagnale A, Marra L, Portella G, et al. Aurora B expression in post-puberal testicular germ cell tumours. J Cell Physiol 2009; 221:435-9.
32. Boscia F, Gala R, Pannaccione A, Secondo A, Scorziello A, Di Renzo G, et al. NCX1 expression and functional activity increase in microglia invading the infarct core. Stroke 2009; 40:3608-17.